A Phase IV Study of Huazhi Rougan Granule

PHASE4CompletedINTERVENTIONAL

Enrollment

282

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

November 8, 2018

Study Completion Date

November 8, 2018

Conditions

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Interventions

DRUG

Huazhi Rougan Granule Placebo granule

Experimental: Huazhi Rougan granule Placebo Comparator: Placebo granule Placebo Comparator: Placebo granule

Trial Locations (1)

Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai

All Listed Sponsors

lead

Shandong New Time Pharmaceutical Co., LTD

INDUSTRY

NCT06188611 - A Phase IV Study of Huazhi Rougan Granule | Biotech Hunter | Biotech Hunter